-

Health Professionals Petition WHO for Guidance: People Should Use Nasal Sprays to Combat COVID-19 Pandemic; Doctors Use in Treating Patients

“Studies show nasal sprays, such as Xlear, reduces risk of COVID-19 transmission and infection”

WASHINGTON--(BUSINESS WIRE)--Today, a consortium of health professionals petitioned the World Health Organization to issue Guidance calling on: all people to use nasal sprays to combat the COVID-19 pandemic; doctors to use them in treating COVID-19 patients; and, Member-States to implement public health policies promoting the use of nasal sprays to both prevent and treat COVID-19.

The petition asks the WHO to promulgate guidance that promotes the use of nasal sprays with data indicating that they are antiviral (blocks viral adhesion), virucidal (kills or deactivates the virus), anti-bacterial (block bacteria, in particular pneumonia bacteria) and bactericidal (kills bacteria, in particular pneumonia bacteria).

“We have data showing that certain nasal sprays don’t just wash away the virus. Certain sprays actually block, deactivate and/or kill the virus,” said Dr. Gustavo Ferrer, a respiratory illness expert who has conducted research on the use of nasal sprays to combat COVID-19, and is among the petitioners.

As a result, the petition calls specifically for WHO Guidance to focus on the use of nasal sprays that contain Xylitol and grapefruit seed extract. Recent studies have found that these natural components used together are antiviral (they block SARS-CoV-2 adhesion to the nasal membrane) and virucidal (they kill or deactivate the virus). One such spray, Xlear, is currently widely available in the US. Xlear has been used by millions of people worldwide, over twenty-plus years, without any adverse effects reported.

Additionally, a new, small clinical study found Xlear lessens the severity and shortens the duration of COVID-19 illnesses, and reduces the risk of further transmission, which is why the petition calls for guidance to doctors to use it as an adjunct to current treatments.

“Nasal sprays are proven safe, inexpensive, non-invasive, easy to use and you can get them off-the-shelf at your local store around the world. There is a growing body of data that sprays, in particular Xlear, can help combat the COVID-19 pandemic. It’s pure commonsense,” Nathan Jones, CEO of Xlear said.

Contacts

Jeff Gulko
617.304.7339
jeff@thegulkogroup.com

Xlear


Release Summary
Health Professionals Petition WHO for Guidance: People Should Use Nasal Sprays to Combat COVID-19 Pandemic; Doctors Use in Treating Patients

Contacts

Jeff Gulko
617.304.7339
jeff@thegulkogroup.com

More News From Xlear

DOJ Asks Court to Dismiss FTC-Xlear Lawsuit

AMERICAN FORK, Utah--(BUSINESS WIRE)--DOJ ASKS COURT TO DISMISS FTC-XLEAR LAWSUIT; Calls into Question FTC’s Authority to Require Clinical Studies for Non-Pharmaceutical Health Products...

One Week Until the 5th Anniversary of National “Wash Your Nose” Day March 11, 2025

AMERICAN FORK, Utah--(BUSINESS WIRE)--One Week Until the 5th Anniversary of National “Wash Your Nose” Day March 11, 2025...

Nathan Jones, CEO of Xlear, Inc., Submits Testimony Supporting Robert F. Kennedy Jr.'s Nomination as Health and Human Services Secretary

WASHINGTON--(BUSINESS WIRE)--Nathan Jones, CEO of Xlear, Inc. (pronounced "Clear"), officially submitted testimony to the Senate Committee on Health, Education, Labor and Pensions in support of Robert F. Kennedy Jr.'s nomination as Secretary of Health and Human Services (HHS). Jones’ compelling testimony underscores the urgent need for innovative, transparent, and preventative approaches to health—priorities which he believes Kennedy is uniquely positioned to champion. Jones’ testimony was acco...
Back to Newsroom